Roni Giladi - Sapiens International Chief Officer
SPNS Stock | USD 27.04 0.02 0.07% |
Executive
Mr. Roni Giladi is the Chief Financial Officer of Sapiens International CorporationrationNV. Prior to joining the Company, Mr. Giladi served as the Director of Finance at Emblaze from January 2007. Prior to joining Emblaze, Mr. Giladi served as Chief Financial Officer of RichFX, from August 2003 until November 2006, after serving as Corporationrationrate Controller from June 2002. Prior to RichFX, Mr. Giladi worked at Ernst Young Israel, from 19972002, as a manager in the hightech practice group. From July 2007 until July 2010, Mr. Giladi served as a director of MediRisk Solutions Ltd., as the nominee of the Company since 2007.
Age | 53 |
Tenure | 18 years |
Address | Azrieli Center, Holon, Israel, 5885800 |
Phone | 972 3 790 2000 |
Web | https://www.sapiens.com |
Sapiens International Management Efficiency
The company has return on total asset (ROA) of 0.0777 % which means that it generated a profit of $0.0777 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1556 %, meaning that it created $0.1556 on every $100 dollars invested by stockholders. Sapiens International's management efficiency ratios could be used to measure how well Sapiens International manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.19 in 2025. Return On Capital Employed is likely to gain to 0.17 in 2025. At this time, Sapiens International's Fixed Asset Turnover is comparatively stable compared to the past year. Return On Assets is likely to gain to 0.11 in 2025, whereas Intangibles To Total Assets are likely to drop 0.29 in 2025.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Jennifer Ortiz | Progress Software | 49 | |
Erica Stoecker | ePlus inc | N/A | |
Rob Thomas | Manhattan Associates | N/A | |
Pawan Joshi | E2open Parent Holdings | 53 | |
Elias Olmeta | Meridianlink | 57 | |
Matthew Campobasso | Enfusion | 46 | |
Kayla JD | Meridianlink | N/A | |
Lisa Horner | Appfolio | N/A | |
Matthew Baird | Appfolio | N/A | |
Joe Frassica | Paycor HCM | N/A | |
Matt Mazza | Appfolio | 48 | |
Shannon Tatz | PROS Holdings | N/A | |
Fay Goon | Appfolio | 47 | |
Matt Campobasso | Enfusion | N/A | |
Garo Toomajanian | Guidewire Software | N/A | |
Said Akar | PDF Solutions | N/A | |
Sundar Subramanian | Progress Software | 45 | |
McLure Foote | Appfolio | N/A | |
Scott CPA | PROS Holdings | 57 | |
Suzanne Hough | Manhattan Associates | N/A | |
Michael Jahoda | PROS Holdings | 45 |
Management Performance
Return On Equity | 0.16 | ||||
Return On Asset | 0.0777 |
Sapiens International Leadership Team
Elected by the shareholders, the Sapiens International's board of directors comprises two types of representatives: Sapiens International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sapiens. The board's role is to monitor Sapiens International's management team and ensure that shareholders' interests are well served. Sapiens International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sapiens International's outside directors are responsible for providing unbiased perspectives on the board's policies.
Hagit Ashkenazi, Executive Services | ||
Roni Giladi, Chief Officer | ||
Gary Sherne, EVP America | ||
Osnat SegevHarel, Head Development | ||
Asaf Amiel, Chief Officer | ||
Dina Vince, Head Relations | ||
Roni CPA, CFO VP | ||
Yaffa CohenIfrah, Chief Marketing Officer, Head of Corporate Communications | ||
Noa Brummer, Chief Officer | ||
Ilan Buganim, Chief Officer | ||
Tally Porat, Director Marketing | ||
Alex Zukerman, Chief Officer | ||
Roni AlDor, CEO President | ||
Rodrigo Rueda, Sales Director | ||
Liana Gelikas, President Division | ||
Raj Ghuman, Senior APAC |
Sapiens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sapiens International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.16 | ||||
Return On Asset | 0.0777 | ||||
Profit Margin | 0.13 % | ||||
Operating Margin | 0.16 % | ||||
Current Valuation | 1.4 B | ||||
Shares Outstanding | 55.89 M | ||||
Shares Owned By Insiders | 45.06 % | ||||
Shares Owned By Institutions | 37.63 % | ||||
Number Of Shares Shorted | 192.99 K | ||||
Price To Earning | 29.52 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sapiens Stock Analysis
When running Sapiens International's price analysis, check to measure Sapiens International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sapiens International is operating at the current time. Most of Sapiens International's value examination focuses on studying past and present price action to predict the probability of Sapiens International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sapiens International's price. Additionally, you may evaluate how the addition of Sapiens International to your portfolios can decrease your overall portfolio volatility.